Table 3.
Individual-level data of egg-patent infection and urinary tract pathology among the cohort of women examined in 2000 and again in 2014.
| 2000 | 2014 | |||
|---|---|---|---|---|
| Characteristics | n | % of total (N=93) (95% CI) | n | % of total (N=93) (95% CI) |
| Egg-patent infection | 32 | 34 (25 to 44) | 8 | 9 (3 to 14) |
| Any urinary tract pathology | 14 | 15 (8 to 22) | 18 | 19 (11 to 28) |
| Upper tract pathology | 6 | 6 (1 to 11) | 4 | 4 (0.1 to 8) |
| Any bladder abnormality | 9 | 10 (4 to 16) | 15 | 16 (8 to 24) |
| Abnormal shape | 1 | 1 (0 to 3) | 3 | 3 (0 to 7) |
| Bladder irregularity | 0 | – | 1 | 1 (0 to 3) |
| Wall thickening | 8 | 9 (3 to 14) | 12 | 13 (6 to 20) |
| Masses | 0 | – | 2 | 2 (0 to 5) |
| Pseudopolyps | 0 | – | 0 | – |